ArriVent BioPharma (AVBP) Payables (2023 - 2026)
ArriVent BioPharma (AVBP) reported Payables of $8.7 million for Q1 2026, up 99.98% on a YoY basis from $4.4 million in Q1 2025, and up 47.07% sequentially from $5.9 million in Q4 2025.
ArriVent BioPharma (AVBP) Payables (2023 - 2026) Analysis & Trends
ArriVent BioPharma (AVBP) has 4 years of Payables data on file, last reported at $8.7 million in Q1 2026.
- For the quarter ending Q1 2026, Payables rose 99.98% year-over-year to $8.7 million; the trailing twelve-month figure through Mar 2026 stood at $8.7 million (up 99.98% YoY), and the FY2025 full-year result was $5.9 million, up 56.9% from the prior year.
- Payables rose to $8.7 million in Q1 2026, from $5.9 million in the prior quarter.
- In the past five years, Payables ranged from a high of $8.7 million in Q1 2026 to a low of $3.8 million in Q4 2024.
- A 4-year average of $5.0 million and a median of $4.4 million in 2023 frame the typical range for Payables.
- Across the five-year window, Payables slipped 16.55% in 2024 and jumped 99.98% in 2026, its largest moves.
- Tracing AVBP's Payables over 4 years: stood at $4.5 million in 2023, then declined by 16.55% to $3.8 million in 2024, then jumped by 56.9% to $5.9 million in 2025, then jumped by 47.07% to $8.7 million in 2026.
- Business Quant data shows AVBP's Payables at $8.7 million in Q1 2026, $5.9 million in Q4 2025, and $5.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 5.74 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 10.62 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 423.55 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 694,346.76 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 489.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.03 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.52 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 80.54 Mn |
| 10 | ArriVent BioPharma | 1.42 Bn | 1.42 Bn | - | 8.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.73 Mn |
| Dec 31, 2025 | 5.93 Mn |
| Sep 30, 2025 | 5.93 Mn |
| Jun 30, 2025 | 4.06 Mn |
| Mar 31, 2025 | 4.36 Mn |
| Dec 31, 2024 | 3.78 Mn |
| Sep 30, 2024 | 4.65 Mn |
| Jun 30, 2024 | 3.81 Mn |
| Mar 31, 2024 | 4.10 Mn |
| Dec 31, 2023 | 4.53 Mn |